Parenteral Delivery
Parenteral Delivery - Related Videos
01:29
Drug Delivery: Parenteral Route
0 Views •
2024
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally. There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:28
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
0 Views •
2026
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:24
Parenteral Anesthetics: Overview
0 Views •
2024
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:25
Routes of Drug Administration: Parenteral
0 Views •
2023
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism. The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily. The IV route is often...
00:04
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
0 Views •
2019
Here, we present a protocol for a study comparing the efficacy, safety, and delivery of olive-oil-based 3CB and soybean-oil-based CoB formulations in adults requiring parenteral nutrition. The results revealed that olive-oil-based 3CBs is non-inferior and well tolerated compared to soybean formulations.
FAQs
Route choice changes how quickly and predictably a substance reaches systemic circulation. Intravenous administration introduces the formulation directly into the bloodstream, whereas intramuscular, subcutaneous, and intradermal routes place it in tissues first. Consequently, absorption and onset are shaped not only by the selected route, but also by the formulation and the injection site.
The formulation and injection site are active determinants of performance, not merely logistical details. A formulation must be sterile and compatible with the tissue receiving it, while dose accuracy influences the amount administered. These controls help determine whether the intended exposure is achieved safely, particularly when the goal is rapid, reliable, or controlled systemic treatment.
Parenteral delivery becomes especially valuable when oral treatment would not provide dependable exposure. Bypassing the gastrointestinal tract can support therapies that are poorly absorbed or degraded orally, while also enabling rapid, reliable, or controlled systemic exposure. The choice therefore reflects the therapeutic substance and clinical objective, rather than convenience alone.
Safe administration requires coordinated attention to sterility, dose accuracy, tissue compatibility, route, formulation, and injection site. The clinician must match these factors to the intended exposure and treatment purpose, then introduce the substance through the selected route. This preparation reduces avoidable problems related to contamination, inaccurate dosing, or tissue incompatibility.
Its clinical value extends across several distinct needs: emergency treatment can benefit from dependable systemic exposure, vaccination uses an administration route outside the gastrointestinal tract, and fluids or nutrients can be delivered when replacement is required. The same approach also supports substances that oral treatment cannot reliably absorb or preserve.
Route selection links the administration site to expected absorption and onset. Intravenous delivery introduces a substance directly into the bloodstream, while tissue-based routes require absorption from the injection site. Considering the formulation and site alongside the route helps align administration with whether treatment requires rapid, reliable, or controlled systemic exposure.